Literature DB >> 30165156

Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: A randomized crossover trial.

A Roy-Fleming1, N Taleb2, V Messier3, C Suppère3, C Cameli3, S Elbekri3, M R Smaoui4, M Ladouceur5, L Legault6, R Rabasa-Lhoret7.   

Abstract

AIMS: To compare the efficacy of three timings to decrease basal insulin infusion rate to reduce exercise-induced hypoglycaemia in patients with type 1 diabetes (T1D) using pump therapy.
METHODS: A single-blinded, randomized, 3-way crossover study in 22 adults that had T1D > 1 year and using insulin pump > 3 months (age, 40 ± 15 years; HbA1c, 56.3 ± 10.2 mmol/mol). Participants practiced three 45-min exercise sessions (ergocyle) at 60% VO2peak 3 hours after lunch comparing an 80% reduction of basal insulin applied 40 minutes before (T-40), 20 minutes before (T-20) or at exercise onset (T0).
RESULTS: No significant difference was observed for percentage of time spent < 4.0 mmol/L (T-40: 16 ± 25%; T-20: 26 ± 27%; T0: 24 ± 29%) (main outcome) and time spent in target range 4.0-10.0 mmol/L (T-40: 63 ± 37%; T-20: 66 ± 25%; T0: 65 ± 31%). With T-40 strategy, although not significant, starting blood glucose (BG) was higher (T-40: 8.6 ± 3.6 mmol/L; T-20: 7.4 ± 2.5 mmol/L ; T0: 7.4 ± 2.7 mmol/L), fewer patients needed extra carbohydrates consumption prior to exercise for BG < 5.0 mmol/L (T-40: n = 3; T-20: n = 5; T0: n = 6) as well as during exercise for BG < 3.3 mmol/L [T-40: n = 6 (27%); T-20: n = 12 (55%); T0: n = 11 (50%)] while time to first hypoglycaemic episode was delayed (T-40: 28 ± 14 min; T-20: 24 ± 10 min; T0: 22 ± 11 min).
CONCLUSION: Decreasing basal insulin infusion rate by 80% up to 40 minutes before exercise onset is insufficient to reduce exercise-induced hypoglycaemia.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CSII; Exercise; Hypoglycaemia; Insulin pump; Type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30165156     DOI: 10.1016/j.diabet.2018.08.002

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

Review 1.  Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future Perspectives.

Authors:  Sémah Tagougui; Nadine Taleb; Joséphine Molvau; Élisabeth Nguyen; Marie Raffray; Rémi Rabasa-Lhoret
Journal:  J Diabetes Sci Technol       Date:  2019-08-13

2.  In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.

Authors:  Jose Garcia-Tirado; Patricio Colmegna; John P Corbett; Basak Ozaslan; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2019-11

Review 3.  The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes.

Authors:  Sémah Tagougui; Nadine Taleb; Rémi Rabasa-Lhoret
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-18       Impact factor: 5.555

Review 4.  Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".

Authors:  Addisu Dabi Wake
Journal:  World J Diabetes       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.